Metacrine Inc (MTCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -62,207 | -37,304 | -28,933 | N/A | N/A |
| Depreciation Amortization | 972 | 931 | 830 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,650 | -503 | 44 | N/A | N/A |
| Other Working Capital | 6,442 | -5,258 | -1,019 | N/A | N/A |
| Other Operating Activity | 3,983 | 5,923 | 1,330 | 0 | 0 |
| Operating Cash Flow | $-47,160 | $-36,211 | $-27,748 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 43,918 | -31,891 | 17,781 | N/A | N/A |
| PPE Investments | -8 | -206 | -84 | N/A | N/A |
| Investing Cash Flow | $43,910 | $-32,097 | $17,697 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,825 | 0 | 9,717 | N/A | N/A |
| Common Stock Issued | 22,943 | 77,035 | 38 | N/A | N/A |
| Common Stock Repurchased | -1 | -2 | -1 | N/A | N/A |
| Financing Cash Flow | $27,767 | $77,033 | $9,754 | $N/A | $N/A |
| Beginning Cash Position | 24,393 | 15,668 | 15,965 | N/A | N/A |
| End Cash Position | 48,910 | 24,393 | 15,668 | N/A | N/A |
| Net Cash Flow | $24,517 | $8,725 | $-297 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,160 | -36,211 | -27,748 | N/A | N/A |
| Capital Expenditure | -8 | -206 | -84 | N/A | N/A |
| Free Cash Flow | -47,168 | -36,417 | -27,832 | 0 | 0 |